Finance

Lists
ATOS:NASDAQ
Atossa Therapeutics Inc
$2.46
+0.41%
(+0.0100) 1D
Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATOS...
Open
$2.41
High
$2.49
Low
$2.41
Mkt. cap
24.55M
Avg. vol.
58.11K
Volume
0.00
52-wk high
$19.35
52-wk low
$1.70
EPS
-$4.34
Beta
1.27
Shares outstanding
9.98M
No. of employees
16
Open
$2.41
High
$2.49
Low
$2.41
Mkt. cap
24.55M
Avg. vol.
58.11K
Volume
0.00
52-wk high
$19.35
52-wk low
$1.70
EPS
-$4.34
Beta
1.27
Shares outstanding
9.98M
No. of employees
16
News stories
From web sources and news partners
About Atossa Therapeutics Inc
CEOSteven C. Quay
Employees16
Founded2008
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteatossatherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to ATOS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ATOS in the last 3 months.
Highest
Current $2.46
$25.00 (+916.26%)
Average
$17.50 (+611.38%)
Lowest
$10.00 (+306.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
$25.00
+916.3%
09/30/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+306.5%
08/11/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$12.00
+387.8%
07/07/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$25.00
+916.3%
05/08/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
$10.00
+306.5%
02/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.37M
6.16M
4.78M
4.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.88M
5.28M
5.09M
3.80M
Operating expense
9.25M
11.44M
9.87M
8.69M
Total operating expenses
9.25M
11.44M
9.87M
8.69M
Operating income
-9.25M
-11.44M
-9.87M
-8.69M
Other non operating income
-11.00K
57.00K
-28.00K
-24.00K
EBT including unusual items
-8.69M
-10.94M
-9.59M
-8.49M
EBT excluding unusual items
-8.69M
-10.94M
-9.59M
-8.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.69M
-10.94M
-9.59M
-8.49M
Net profit margin
-
-
-
-
Earnings per share
-1.05
-1.34
-1.11
-0.95
Interest and investment income
570.00K
442.00K
309.00K
227.00K
Interest expense
-
-
-
-
Net interest expenses
570.00K
442.00K
309.00K
227.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.25M
-11.43M
-9.87M
-8.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps